All In Biotech

Drug Trial Radar · NCT00988429

Efficacy and Safety of Eslicarbazepine Acetate (BIA 2-093) as Adjunctive Therapy for Refractory Partial Seizures

Efficacy and Safety of Eslicarbazepine Acetate (BIA 2-093) as Adjunctive Therapy for Refractory Partial Seizures in a Double-blind, Randomised, Placebo-controlled, Parallel-group, Multicentre Trial

Last checked: Nov 20, 2026Latest source record: May 19, 2021 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedResults posted on the registryPivotal-lookingPhase 3. Randomized with 653 participants. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

653

Actual

Start

Dec 2, 2008

Primary completion

Jan 12, 2012

Study completion Jan 12, 2012

Sponsor

Lead sponsor
Bial - Portela C S.A.Industry
Sponsor type
Industry
Collaborators
Sumitomo Pharma America, Inc.
First posted
Oct 2, 2009

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Randomized
Model
Parallel
Masking
Quadruple (participant, care provider, investigator, outcomes assessor)
Primary purpose
Treatment
Who can join
All sexes, from 16 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The purpose of this study is to determine whether Eslicarbazepine acetate (BIA 2-093) is an effective adjunct therapy in the treatment of refractory partial seizures

Conditions

  • Partial Epilepsy

Interventions

  • 800 mg QD Eslicarbazepine acetateDrug

    Oral, 800 mg QD, 2-week titration period and 12-week maintenance period

  • 1200 mg QD Eslicarbazepine acetateDrug

    Oral, 1200 mg QD, 2-week titration followed by 12-week maintenance period

  • PlaceboDrug

    Placebo tablet given QD

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Seizure Frequency Over the 12-week Maintenance Period.Time frame: 12-week maintenance period (Week 3 to week 14)

Locations

162 sites in 11 countries. Site status is shown where the registry gives one.

  • University of South Alabama Department of Neurology

    Mobile, Alabama

  • Neurology Clinic, P.C.

    Northport, Alabama

  • 21st Century Neurology - Division of Xenoscience, Inc.

    Phoenix, Arizona

  • Barrow Neurological Institute / St. Joseph's Hospital and Medical Center

    Phoenix, Arizona

  • Phoenix Neurological Associates/Clinical Research Advantage

    Phoenix, Arizona

  • ANI Research, PC

    Sun City, Arizona

  • University of Arizona Health Sciences Center

    Tucson, Arizona

  • Arkansas Neurology

    Conway, Arkansas

  • Clinical Trials Inc.

    Little Rock, Arkansas

  • Kern County Neurological Medical Group, INC.

    Bakersfield, California

  • Neuro-Pain Medical Center, Inc.

    Fresno, California

  • Loma Linda University

    Loma Linda, California

  • Collaborative Neuroscience Network, INC

    Long Beach, California

  • Viking Clinical Research Center

    Murrieta, California

  • Bright Minds Institute

    San Francisco, California

  • Milestone Clinical Research

    San Jose, California

  • Neurosearch II, Inc.

    Ventura, California

  • University of Colorado Health Sciences

    Aurora, Colorado

  • Denver Health

    Denver, Colorado

  • Bradenton Research Center

    Bradenton, Florida

  • Optima Neurological Services, LLC

    Gainesville, Florida

  • University of Florida Department of Neurology

    Gainesville, Florida

  • NW FL Clinical Research Group, LLC

    Gulf Breeze, Florida

  • Palm Springs Research Institute

    Hialeah, Florida

  • University of Florida

    Jacksonville, Florida

  • Pharmax Research Clinic

    Miami, Florida

  • Advanced Pharma CR, LLC

    Miami, Florida

  • University of Miami - Miller School of Medicine Department of Neurology

    Miami, Florida

  • Miami Children's Hospital

    Miami, Florida

  • Neuroscience Consultants

    Miami, Florida

  • Kendall South Medical Center, Inc.

    Miami, Florida

  • Medsol Clinical Research Center

    Port Charlotte, Florida

  • Lovelace Scientific Resources

    Sarasota, Florida

  • University of South Florida - Department of Neurology

    Tampa, Florida

  • Pediatric Epilepsy & Neurology Specialists, PA

    Tampa, Florida

  • Lovelace Scientific Resources

    Venice, Florida

  • Palm Beach Clinical Research Network, LLC.

    Wellington, Florida

  • Harbin Clinic

    Rome, Georgia

  • Consultants in Epilepsy and Neurology, PPLC

    Boise, Idaho

  • Southern Ilinois University School of Medicine

    Springfield, Illinois

Showing 40 of 162 sites, US sites first. The full list is on the registry record.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.